Rama Raghavan – Medall
View Detailed Executive Profile →Professional Overview
- Rama Raghavan co-founded Medall in April 2010, contributing to the establishment of a company focused on innovative healthcare solutions.
- Under the leadership of Rama Raghavan, Medall has significantly impacted the healthcare sector through the development of advanced medical technologies.
- Prior to founding Medall, Rama Raghavan gained experience as a medical representative at Novartis from January 1994 until January 1998, providing insights into the pharmaceutical industry.
- Rama Raghavan's background in the medical field helped shape Medall's mission and strategic direction, emphasizing patient-centered care.
- Medall has sought to address various challenges in healthcare delivery, focusing on improving access to medical services and enhancing patient outcomes.
- Through Medall, Rama Raghavan has championed the use of data analytics and technology to drive efficiencies in healthcare management.
- The organization has celebrated several milestones, including notable partnerships and collaborations aimed at expanding the reach of its healthcare solutions.
- Rama Raghavan's vision for Medall includes continuous innovation to meet the evolving needs of healthcare providers and patients alike.
Professional Experience
| Company | Designation | Period |
|---|---|---|
| Novartis | medical rep | Jan 1994 – Jan 1998 |
| Medall | Co-Founder | Apr 2010 – Present |
Estimated Net Worth
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Medall corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Rama Raghavan's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Medall's official communication channels.
Is this an official profile?
No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)